|
1
|
Shaw JE, Sicree RA and Zimmet PZ: Global
estimates of the prevalence of diabetes for 2010 and 2030. Diabetes
Res Clin Pract. 87:4–14. 2010. View Article : Google Scholar
|
|
2
|
Atkinson MA and Eisenbarth GS: Type 1
diabetes: New perspectives on disease pathogenesis and treatment.
Lancet. 358:221–229. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Nyenwe EA, Jerkins TW, Umpierrez GE and
Kitabchi AE: Management of type 2 diabetes: Evolving strategies for
the treatment of patients with type 2 diabetes. Metabolism.
60:1–23. 2011. View Article : Google Scholar
|
|
4
|
Mishra PK, Singh SR, Joshua IG and Tyagi
SC: Stem cells as a therapeutic target for diabetes. Front Biosci
(Landmark Ed). 15:461–477. 2010. View
Article : Google Scholar
|
|
5
|
Couri CE and Voltarelli JC: Stem
cell-based therapies and immunomodulatory approaches in newly
diagnosed type 1 diabetes. Curr Stem Cell Res Ther. 6:10–15. 2011.
View Article : Google Scholar
|
|
6
|
Ezquer FE, Ezquer ME, Parrau DB, Carpio D,
Yañez AJ and Conget PA: Systemic administration of multipotent
mesenchymal stromal cells reverts hyperglycemia and prevents
nephropathy in type 1 diabetic mice. Biol Blood Marrow Transplant.
14:631–640. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Deans RJ and Moseley AB: Mesenchymal stem
cells: Biology and potential clinical uses. Exp Hematol.
28:875–884. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Conget P, Rodriguez F, Kramer S, Allers C,
Simon V, Palisson F, Gonzalez S and Yubero MJ: Replenishment of
type VII collagen and re-epithelialization of chronically ulcerated
skin after intra-dermal administration of allogeneic mesenchymal
stromal cells in two patients with recessive dystrophic
epidermolysis bullosa. Cytotherapy. 12:429–431. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Barry FP and Murphy JM: Mesenchymal stem
cells: Clinical applications and biological characterization. Int J
Biochem Cell Biol. 36:568–584. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Tang DQ, Cao LZ, Burkhardt BR, Xia CQ,
Litherland SA, Atkinson MA and Yang LJ: In vivo and in vitro
characterization of insulin-producing cells obtained from murine
bone marrow. Diabetes. 53:1721–1732. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Thakkar UG, Trivedi HL, Vanikar AV and
Dave SD: Insulin-secreting adipose-derived mesenchymal stromal
cells with bone marrow-derived hematopoietic stem cells from
autologous and allogenic sources for type 1 diabetes mellitus.
Cytotherapy. 17:940–947. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Heineman FW and Balaban RS: Phosphorus-31
nuclear magnetic resonance analysis of transient changes of canine
myocardial metabolism in vivo. J Clin Invest. 85:843–852. 1990.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Ben-Ami E, Berrih-Aknin S and Miller A:
Mesenchymal stem cells as an immunomodulatory therapeutic strategy
for autoimmune diseases. Autoimmun Rev. 10:410–415. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Maccario R, Podestà M, Moretta A, Cometa
A, Comoli P, Montagna D, Daudt L, Ibatici A, Piaggio G, Pozzi S, et
al: Interaction of human mesenchymal stem cells with cells involved
in alloantigen-specific immune response favors the differentiation
of CD4+ T-cell subsets expressing a
regulatory/suppressive phenotype. Haematologica. 90:516–525.
2005.PubMed/NCBI
|
|
15
|
Rasmusson I, Ringdén O, Sundberg B and Le
Blanc K: Mesenchymal stem cells inhibit lymphocyte proliferation by
mitogens and alloantigens by different mechanisms. Exp Cell Res.
305:33–41. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Rasmusson I: Immune modulation by
mesenchymal stem cells. Exp Cell Res. 312:2169–2179. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Phinney DG and Prockop DJ: Concise review:
mesenchymal stem/multipotent stromal cells: the state of
transdifferentiation and modes of tissue repair - current views.
Stem Cells. 25:2896–2902. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Caplan AI and Dennis JE: Mesenchymal stem
cells as trophic mediators. J Cell Biochem. 98:1076–1084. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zhang R: Lipasin, a novel
nutritionally-regulated liver-enriched factor that regulates serum
triglyceride levels. Biochem Biophys Res Commun. 424:786–792. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Quagliarini F, Wang Y, Kozlitina J,
Grishin NV, Hyde R, Boerwinkle E, Valenzuela DM, Murphy AJ, Cohen
JC and Hobbs HH: Atypical angiopoietin-like protein that regulates
ANGPTL3. Proc Natl Acad Sci USA. 109:19751–19756. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Yi P, Park JS and Melton DA: Betatrophin:
A hormone that controls pancreatic β cell proliferation. Cell.
153:747–758. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Wang Y, Quagliarini F, Gusarova V, Gromada
J, Valenzuela DM, Cohen JC and Hobbs HH: Mice lacking ANGPTL8
(Betatrophin) manifest disrupted triglyceride metabolism without
impaired glucose homeostasis. Proc Natl Acad Sci USA.
110:16109–16114. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Chen X, Lu P, He W, Zhang J, Liu L, Yang
Y, Liu Z, Xie J, Shao S, Du T, et al: Circulating betatrophin
levels are increased in patients with type 2 diabetes and
associated with insulin resistance. J Clin Endocrinol Metab.
100:E96–E100. 2015. View Article : Google Scholar
|
|
24
|
Gómez-Ambrosi J, Pascual E, Catalán V,
Rodríguez A, Ramírez B, Silva C, Gil MJ, Salvador J and Frühbeck G:
Circulating betatrophin concentrations are decreased in human
obesity and type 2 diabetes. J Clin Endocrinol Metab.
99:E2004–E2009. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Kugelberg E: Diabetes: Betatrophin -
inducing β-cell expansion to treat diabetes mellitus? Nat Rev
Endocrinol. 9:3792013. View Article : Google Scholar
|
|
26
|
Izadpanah R, Joswig T, Tsien F, Dufour J,
Kirijan JC and Bunnell BA: Characterization of multipotent
mesenchymal stem cells from the bone marrow of rhesus macaques.
Stem Cells Dev. 14:440–451. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Sekiya I, Colter DC and Prockop DJ: BMP-6
enhances chondrogenesis in a subpopulation of human marrow stromal
cells. Biochem Biophys Res Commun. 284:411–418. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Yeung TY, Seeberger KL, Kin T, Adesida A,
Jomha N, Shapiro AM and Korbutt GS: Human mesenchymal stem cells
protect human islets from pro-inflammatory cytokines. PLoS One.
7:e381892012. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Isaac R, Boura-Halfon S, Gurevitch D,
Shainskaya A, Levkovitz Y and Zick Y: Selective serotonin reuptake
inhibitors (SSRIs) inhibit insulin secretion and action in
pancreatic β cells. J Biol Chem. 288:5682–5693. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Bivalacqua TJ, Usta MF, Kendirci M,
Pradhan L, Alvarez X, Champion HC, Kadowitz PJ and Hellstrom WJ:
Superoxide anion production in the rat penis impairs erectile
function in diabetes: Influence of in vivo extracellular superoxide
dismutase gene therapy. J Sex Med. 2:187–198. 2005. View Article : Google Scholar
|
|
31
|
Dominici M, Le Blanc K, Mueller I,
Slaper-Cortenbach I, Marini F, Krause D, Deans R, Keating A,
Prockop DJ and Horwitz E: Minimal criteria for defining multipotent
mesenchymal stromal cells. The International Society for Cellular
Therapy position statement. Cytotherapy. 8:315–317. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Kögler G, Sensken S, Airey JA, Trapp T,
Müschen M, Feldhahn N, Liedtke S, Sorg RV, Fischer J, Rosenbaum C,
et al: A new human somatic stem cell from placental cord blood with
intrinsic pluripotent differentiation potential. J Exp Med.
200:123–135. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Niemeyer P, Krause U, Fellenberg J, Kasten
P, Seckinger A, Ho AD and Simank HG: Evaluation of mineralized
collagen and alpha-tricalcium phosphate as scaffolds for tissue
engineering of bone using human mesenchymal stem cells. Cells
Tissues Organs. 177:68–78. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Rackham CL, Dhadda PK, Chagastelles PC,
Simpson SJ, Dattani AA, Bowe JE, Jones PM and King AJ:
Pre-culturing islets with mesenchymal stromal cells using a direct
contact configuration is beneficial for transplantation outcome in
diabetic mice. Cytotherapy. 15:449–459. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Donath MY and Shoelson SE: Type 2 diabetes
as an inflammatory disease. Nat Rev Immunol. 11:98–107. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Barshes NR, Wyllie S and Goss JA:
Inflammation-mediated dysfunction and apoptosis in pancreatic islet
transplantation: Implications for intrahepatic grafts. J Leukoc
Biol. 77:587–597. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Biarnés M, Montolio M, Nacher V, Raurell
M, Soler J and Montanya E: Beta-cell death and mass in
syngeneically transplanted islets exposed to short- and long-term
hyperglycemia. Diabetes. 51:66–72. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Zaccone P, Phillips J, Conget I, Gomis R,
Haskins K, Minty A, Bendtzen K, Cooke A and Nicoletti F:
Interleukin-13 prevents autoimmune diabetes in NOD mice. Diabetes.
48:1522–1528. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Kaminski A, Kaminski ER and Morgan NG:
Pre-incubation with interleukin-4 mediates a direct protective
effect against the loss of pancreatic beta-cell viability induced
by proinflammatory cytokines. Clin Exp Immunol. 148:583–588. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Jiang R, Han Z, Zhuo G, Qu X, Li X, Wang
X, Shao Y, Yang S and Han ZC: Transplantation of placenta-derived
mesenchymal stem cells in type 2 diabetes: A pilot study. Front
Med. 5:94–100. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Abdi R, Fiorina P, Adra CN, Atkinson M and
Sayegh MH: Immunomodulation by mesenchymal stem cells: A potential
therapeutic strategy for type 1 diabetes. Diabetes. 57:1759–1767.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Zhu YG, Qu JM, Zhang J, Jiang HN and Xu
JF: Novel interventional approaches for ALI/ARDS: Cell-based gene
therapy. Mediators Inflamm. 2011:5601942011. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Devaney J, Contreras M and Laffey JG:
Clinical review: gene-based therapies for ALI/ARDS: where are we
now? Crit Care. 15:2242011. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Nayak S and Herzog RW: Progress and
prospects: Immune responses to viral vectors. Gene Ther.
17:295–304. 2010. View Article : Google Scholar
|
|
45
|
Raper SE, Chirmule N, Lee FS, Wivel NA,
Bagg A, Gao GP, Wilson JM and Batshaw ML: Fatal systemic
inflammatory response syndrome in a ornithine transcarbamylase
deficient patient following adenoviral gene transfer. Mol Genet
Metab. 80:148–158. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Lu Y, Wang Z and Zhu M: Human bone marrow
mesenchymal stem cells transfected with human insulin genes can
secrete insulin stably. Ann Clin Lab Sci. 36:127–136.
2006.PubMed/NCBI
|
|
47
|
Xu J, Lu Y, Ding F, Zhan X, Zhu M and Wang
Z: Reversal of diabetes in mice by intrahepatic injection of
bone-derived GFP-murine mesenchymal stem cells infected with the
recombinant retrovirus-carrying human insulin gene. World J Surg.
31:1872–1882. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Jiao Y, Le Lay J, Yu M, Naji A and
Kaestner KH: Elevated mouse hepatic betatrophin expression does not
increase human β-cell replication in the transplant setting.
Diabetes. 63:1283–1288. 2014. View Article : Google Scholar :
|
|
49
|
Cox AR, Lam CJ, Bonnyman CW, Chavez J,
Rios JS and Kushner JA: Angiopoietin-like protein 8
(ANGPTL8)/betatrophin overexpression does not increase beta cell
proliferation in mice. Diabetologia. 58:1523–1531. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Volarevic V, Arsenijevic N, Lukic ML and
Stojkovic M: Concise review: Mesenchymal stem cell treatment of the
complications of diabetes mellitus. Stem Cells. 29:5–10. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Sun Y, Chen L, Hou XG, Hou WK, Dong JJ,
Sun L, Tang KX, Wang B, Song J, Li H, et al: Differentiation of
bone marrow-derived mesenchymal stem cells from diabetic patients
into insulin-producing cells in vitro. Chin Med J (Engl).
120:771–776. 2007.
|
|
52
|
Li HT, Jiang FX, Shi P, Zhang T, Liu XY,
Lin XW and Pang XN: In vitro reprogramming of rat bone
marrow-derived mesenchymal stem cells into insulin-producing cells
by genetically manipulating negative and positive regulators.
Biochem Biophys Res Commun. 420:793–798. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Guo QS, Zhu MY, Wang L, Fan XJ, Lu YH,
Wang ZW, Zhu SJ, Wang Y and Huang Y: Combined transfection of the
three transcriptional factors, PDX-1, NeuroD1, and MafA, causes
differentiation of bone marrow mesenchymal stem cells into
insulin-producing cells. Exp Diabetes Res.
2012:6720132012.PubMed/NCBI
|
|
54
|
Wang Y, Chen X, Cao W and Shi Y:
Plasticity of mesenchymal stem cells in immunomodulation:
Pathological and therapeutic implications. Nat Immunol.
15:1009–1016. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Laakso M: Not for the eyes only: AX6 and
glucose metabolism. Diabetologia. 52:381–384. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Lyttle BM, Li J, Krishnamurthy M, Fellows
F, Wheeler MB, Goodyer CG and Wang R: Transcription factor
expression in the developing human fetal endocrine pancreas.
Diabetologia. 51:1169–1180. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
St-Onge L, Sosa-Pineda B, Chowdhury K,
Mansouri A and Gruss P: Pax6 is required for differentiation of
glucagon-producing alpha-cells in mouse pancreas. Nature.
387:406–409. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Grapp M, Teichler S, Kitz J, Dibaj P,
Dickel C, Knepel W and Krätzner R: The homeodomain of AX6 is
essential for AX6-dependent activation of the rat glucagon gene
promoter: Evidence for a PH0 -like binding that induces an active
conformation. Biochim Biophys Acta. 1789:403–412. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Thorel F, Népote V, Avril I, Kohno K,
Desgraz R, Chera S and Herrera PL: Conversion of adult pancreatic
alpha-cells to beta-cells after extreme beta-cell loss. Nature.
464:1149–1154. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Shen J, Cheng Y, Han Q, Mu Y and Han W:
Generating insulin-producing cells for diabetic therapy: Existing
strategies and new development. Ageing Res Rev. 12:469–478. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
61
|
English K: Mechanisms of mesenchymal
stromal cell immunomodulation. Immunol Cell Biol. 91:19–26. 2013.
View Article : Google Scholar
|
|
62
|
Tolar J, Le Blanc K, Keating A and Blazar
BR: Concise review: Hitting the right spot with mesenchymal stromal
cells. Stem Cells. 28:1446–1455. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Kuo YR, Wang CT, Cheng JT, Kao GS, Chiang
YC and Wang CJ: Adipose-derived stem cells accelerate diabetic
wound healing through the induction of autocrine and paracrine
effects. Cell Transplant. 25:71–81. 2016. View Article : Google Scholar
|
|
64
|
Wang H, Qiu X, Ni P, Qiu X, Lin X, Wu W,
Xie L, Lin L, Min J, Lai X, et al: Immunological characteristics of
human umbilical cord mesenchymal stem cells and the therapeutic
effects of their transplantion on hyperglycemia in diabetic rats.
Int J Mol Med. 33:263–270. 2014.
|
|
65
|
Horie M, Choi H, Lee RH, Reger RL,
Ylostalo J, Muneta T, Sekiya I and Prockop DJ: Intra-articular
injection of human mesenchymal stem cells (MSCs) promote rat
meniscal regeneration by being activated to express Indian hedgehog
that enhances expression of type II collagen. Osteoarthritis
Cartilage. 20:1197–1207. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Lin CS, Lin G and Lue TF: Allogeneic and
xenogeneic transplantation of adipose-derived stem cells in
immunocompetent recipients without immunosuppressants. Stem Cells
Dev. 21:2770–2778. 2012. View Article : Google Scholar : PubMed/NCBI
|
